SciELO - Scientific Electronic Library Online

 
vol.83 número2Efecto de la hospitalización sobre la mantención de la lactancia materna en niños menores de 6 meses de edad índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Revista chilena de pediatría

versão impressa ISSN 0370-4106

Resumo

CANO SCH, Francisco; ROJO L, Angélica  e  CEBALLOS O, María Luisa. Chronic renal failure and new molecular marters in pediatrics. Rev. chil. pediatr. [online]. 2012, vol.83, n.2, pp. 117-127. ISSN 0370-4106.  http://dx.doi.org/10.4067/S0370-41062012000200002.

Chronic Renal Failure (CRF) is associated in the mid and long-term to severe complications. New therapies have been introduced in the last decades, however some disturbances as growth failure, mineral metabolism, and anemia, among others, still remain unresolved, and long-term cardiovascular morbimortality remains unacceptable high. In recent years, new molecular markers have been introduced as promising tools in the prevention and management of uremic disturbances. Fibroblast Growth Factor23 (FGF23), Klotho, Hepcidin and growth hormone (GH) intracellular signaling are discussed in this article. FGF23, acting through Klotho protein, increases the rate of urinary excretion of phosphate and inhibits renal production of 1,25-dihydroxy-vitamin D, as an important regulator of mineral metabolism. Hepcidin inhibits intestinal iron absorption and iron release from macrophages and hepatocytes; its production is increased by inflammation and high hepcidin plasma levels limit iron availability for erythropoiesis, playing a major role in the anemia and rhEPO resistance in these patients. In the field of growth, phosphorylation of JAK2 and the downstream GH signaling molecules STAT5, STAT3 and STAT 1 are impaired, leading to decreased IGF-1 DNA gene transduction. Suppressed GH signaling cause up-regulation of SOCS2 and SOCS3 expression and increased tyrosine phosphatase activity contributing to enhance dephosporylation and deactivation of the signaling proteins. The knowledge of the role of these factors in normal physiology will be a central key in the management of uremic patients in the future.

Palavras-chave : Chronic renal failure; anemia; hepcidin; FGF23; Klotho.

        · resumo em Espanhol     · texto em Espanhol     · pdf em Espanhol